Prevalence and family history of colorectal cancer: implications for screening

被引:32
作者
Sandhu, MS [1 ]
Luben, R [1 ]
Khaw, KT [1 ]
机构
[1] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England
关键词
colorectal cancer; family history; screening;
D O I
10.1136/jms.8.2.69
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives-To estimate the current prevalence of family history and associated risk of prevalent colorectal cancer among middle aged and older British adults. Methods-Cross sectional analysis of colorectal cancer and self reported family history based on data from a large population based study in Norfolk, United Kingdom. Results-Of the 30 353 participants, 2069 (6.8%) participants had reported a family history of colorectal cancer in at least one first degree relative. The prevalence of colorectal cancer in those with a family history was 1% and 0.5% in those without. Of the 151 participants with prevalent colorectal cancer, 14.6% reported a family history of the disease. Also, a family history of colorectal cancer in first degree relatives was significantly associated with an increased risk of prevalent colorectal cancer (multivariate odds ratio (OR) 2.32 (95% confidence interval (95% CI) 1.43 to 3.76). For those with one affected relative below the age of 45, and for those with two affected relatives the multivariate ORs were 5.29 (1.63 to 17.17) and 4.93 (1.17 to 20.70), respectively. Conclusions-Although positive family history may identify a group with increased likelihood of colorectal cancer, screening strategies targeted solely at people with a family history will have Limited impact on reducing mortality from colorectal cancer at the population level.
引用
收藏
页码:69 / 72
页数:4
相关论文
共 22 条
[1]   Molecular stool screening for colorectal cancer - Using DNA markers may be beneficial, but large scale evaluation is needed [J].
Ahlquist, DA .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7256) :254-255
[2]   HOW ACCURATE IS SELF-REPORTED FAMILY HISTORY OF COLORECTAL-CANCER [J].
AITKEN, J ;
BAIN, C ;
WARD, M ;
SISKIND, V ;
MACLENNAN, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (09) :863-871
[3]   A comparison of fecal occult-blood tests for colorectal-cancer screening [J].
Allison, JE ;
Tekawa, IS ;
Ransom, LJ ;
Adrain, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :155-159
[4]  
[Anonymous], 1997, INT CLASSIFICATION D
[5]  
ATKIN W, 1999, BRIT MED J, V314, P1779
[6]   Family history and risk of colorectal cancer: implications for screening programmes [J].
Benhamiche-Bouvier, AM ;
Lejeune, C ;
Jouve, JL ;
Manfredi, S ;
Bonithon-Kopp, C ;
Faivre, J .
JOURNAL OF MEDICAL SCREENING, 2000, 7 (03) :136-140
[7]  
Day N, 1999, BRIT J CANCER, V80, P95
[8]   Cancer risk associated with germline DNA mismatch repair gene mutations [J].
Dunlop, MG ;
Farrington, SM ;
Carothers, AD ;
Wyllie, AH ;
Sharp, L ;
Burn, J ;
Liu, B ;
Kinzler, KW ;
Vogelstein, B .
HUMAN MOLECULAR GENETICS, 1997, 6 (01) :105-110
[9]  
DUNLOP MG, 1997, BRIT MED J, V319, P1212
[10]   A PROSPECTIVE-STUDY OF FAMILY HISTORY AND THE RISK OF COLORECTAL-CANCER [J].
FUCHS, CS ;
GIOVANNUCCI, EL ;
COLDITZ, GA ;
HUNTER, DJ ;
SPEIZER, FE ;
WILLETT, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (25) :1669-1674